nance imaging. In Paget's disease, an initial lytic phase is followed by a mixed and a late sclerotic phase. Although the different phases have distinct imaging features, disorganisation of bone structure is a common attribute.
In the third paper of this thematic issue, Muschitz et al. provide a clinical practice guideline for management of the disease and its complications. In addition to imaging studies, biochemical evaluations are crucial for the diagnosis. Bisphosphonates are now considered as the standard treatment for active Paget's disease.
In many publications, Paget's disease of bone has been regarded as the second most frequent metabolic bone disorder. I am convinced that this thematic issue covering basic as well as clinical aspects will increase the awareness of this remarkable and unique bone disease, and will stimulate research activities for the benefit of affected patients.
